2020, Number 4
Clinical epidemiological characterization of pregnant women suspected and positive for covid-19
Language: Spanish
References: 16
Page:
PDF size: 203.07 Kb.
ABSTRACT
Introduction: The medical profession is occupied on the study and treatment of COVID-19, a disease caused by a new coronavirus, called 2019-nCoV. Pregnant women are a high-risk population group for this disease.Objective: To determine the clinical and epidemiological differences of the pregnant women suspect of and positive for COVID-19.
Methods: A descriptive, observational, cross-sectional study was carried out in 56 patients, who were grouped as suspect to COVID-19 and positive. The variables used were age, associated comorbidity, gestational age, presence of symptoms and source of infection. The information was obtained from the clinical records of the pregnant women.
Results: The suspect patients had a mean age of 25 years, 51.0% were in the third trimester of pregnancy, 87.7% had symptoms upon admission, 40.8% had no comorbidity, and in 75, 5% the source of possible contagion was not determined. The positive patients had a mean age of 27 years, 66.6% were in the first trimester of pregnancy, 83.3% were asymptomatic and did not present comorbidity. 50% were contact with positive cases.
Conclusions: There were clinical and epidemiological differences between the suspect and positive patients for COVID-19.
REFERENCES
Pérez Assef A, Rivero Martínez H, Pereda González R, Breto García B, Piloto Padrón M, Oviedo Rodríguez R. Protocolo para el tratamiento de la enfermedad por COVID-19 (SARS-CoV-2) en pacientes obstétricas ingresadas en cuidados intensivos. Revista Cubana de Medicina Intensiva y Emergencias. 2020 [acceso: 15/04/2020];19(2):e74.1-29. Disponible en: http://www.revmie.sld.cu/index.php/mie/article/view/745
Kably-Ambe A, Olavarría-Guadarrama MY, Sánchez Aranda A, Roque-Sánchez AM, Alonso de Mendieta M, López-Marrufo MV. COVID-19 y sus repercusiones en la práctica ginecoobstétrica. Ginecol Obstet Mex. 2020[acceso: 15/04/2020];88:1-12. Disponible en: https://ginecologiayobstetricia.org.mx/article/covid-19-y-sus-repercusiones-en-la-practica-ginecoobstetrica/
Ministerio de Sanidad. Documento técnico: Manejo de la mujer embarazada y el recién nacido con COVID-19. Badajoz: Ministerio de Sanidad; 2020. [acceso:18/04/2020]. Disponible en: Disponible en: https://www.areasaludbadajoz.com/docencia_investigacion/lecturas_recomendadas/Documento_manejo_embarazo_recien_nacido.pdf
Chen H, Guo J, Wang C, Luo F, Yu X. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women a retrospective review of medical records. Lancet. 2020 [acceso: 01/06/2020];395:809-815. Disponible en: https://www.researchgate.net/publication/339216834_Clinical_characteristics_and_intrauterine_vertical_transmission_potential_of_COVID-19_infection_in_nine_pregnant_women_a_retrospective_review_of_medical_records
Segura Fernández A, León Cid I, Urgellés Carreras S, Ramos Zamora V, Herrera Frómeta Columbié, et al. Caracterización clínica de las pacientes obstétricas con sospecha de la COVID-19. Revista Cubana de Medicina Militar. 2020 [acceso: 25/8/2020]; 49(3): [aprox. 12p.]. Disponible en: http://www.revmedmilitar.sld.cu/index.php/mil/article/view/796/540
Asociación Médica Mundial (AMM). Declaración de Helsinki de la AMM:- Principios éticos para las investigaciones médicas en seres humanos. Brasil, Fortaleza: 64ª Asamblea General AMM; 2013 [acceso:18/04/2020]. Disponible en: Disponible en: http://repositorio.mederi.com.co/bitstream/handle/123456789/386/Declaracion-Helsinki-2013-Esp.pdf?sequence=1
Liang H, Acharya G. Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow? Acta Obstet Gynecol Scand. 2020 [acceso:31/05/2020];99(4):439-42. Disponible en: https://www.groupedeveillecovid.fr/wp-content/uploads/2020/03/Liang_et_al-2020-Acta_Obstetricia_et_Gynecologica_Scandinavica.pdf